Silencing Cbl-b expression in breast cancer cells enhanced the risk of lung metastasis in nude mice, and it was concluded that Cbl-b reduces RANK protein expression and inhibits RANKL-induced breast cancer cell migration through negative regulation of the Src-AKT/ERK pathway [13]. Here, AKT1 is linked to breast carcinoma.